Sort
23,748 grants matching “melanoma”
Radiometal Chelates for Targeted Therapy of Melanoma
$228,000Lynn Carol Francesconi · Hunter College · SC1 · FY2009 · CA
Vitiligo in Tyrosinase-specific TCR Transgenic Mice
$228,000University Of Virginia Charlottesville · R21 · FY2004 · AI
Radiometal Chelates for Targeted Therapy of Melanoma
$228,000Lynn Carol Francesconi · Hunter College · SC1 · FY2010 · CA
Characterization of the Immunomic Profile of Head and Neck Cancer
$228,000Nisha J D'silva · University Of Michigan At Ann Arbor · R21 · FY2008 · DE
Control of Eye Melanoma Metastasis
$228,000Emory University · R01 · FY2003 · EY
"Combining radiation with TLR5 agonist based immunotherapy against liver metastases"
$227,984Andrei V Gudkov · Roswell Park Cancer Institute Corp · R21 · FY2019 · CA
Modulation of metabolism in TILs by the checkpoint inhibitor PSGL-1
$227,906Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2021 · CA
Photofrin dark effects and heme oxygenase inducers as therapeutic in mesothelioma
$227,906Theresa M Busch · University Of Pennsylvania · R21 · FY2025 · CA
Targeting Glycolytic Control of Melanoma Cell Survival
$227,895Georg T Wondrak · University Of Arizona · R01 · FY2007 · CA
Targeting Glycolytic Control of Melanoma Cell Survival
$227,895Georg T Wondrak · University Of Arizona · R01 · FY2010 · CA
Targeting Glycolytic Control of Melanoma Cell Survival
$227,895Georg T Wondrak · University Of Arizona · R01 · FY2008 · CA
Targeting Glycolytic Control of Melanoma Cell Survival
$227,895Georg T Wondrak · University Of Arizona · R01 · FY2009 · CA
Cellularly resolved molecular pathway assessment in biopsies via spectral imaging
$227,868Richard M. Levenson · Cambridge Research And Instrumentation · R44 · FY2007 · CA
MINORITY BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM
$227,849University Of South Alabama · U10 · FY2000 · CA
PLANT ANTITUMOR AGENTS
$227,846University Of North Carolina Chapel Hill · R01 · FY2000 · CA
Neural Immune and Genetic Influences on Chronic Pelvic Pain and Endometriosis
$227,828Pamela Stratton · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
Regulation of Chemokine Mediated Leukocyte Functions
$227,823North Carolina Central University · R01 · FY2005 · AI
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Signaling Pathway Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin
$227,817Clara Curiel-Lewandrowski · University Of Arizona · P01 · FY2021 · CA
High Resolution Dermatological Acoustic Microscopy
$227,773J&W Medical, Llc · R43 · FY2004 · ES
Tumor-Specific Chemokine Modulation in Colorectal Cancer Versus Melanoma
$227,763Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA
Plasmacytoid Dendritic Cells in Anti-Tumor Response
$227,715Marco Colonna · Washington University · R01 · FY2008 · CA
Plasmacytoid Dendritic Cells in Anti-Tumor Response
$227,715Marco Colonna · Washington University · R01 · FY2007 · CA
Project 3: Translational Studies and Clinical Pharmacology of TLR4 and TOPK Signaling Pathway Inhibitors for Prevention of Squamous Cell Carcinoma of the Skin
$227,489Clara Curiel-Lewandrowski · University Of Arizona · P01 · FY2023 · CA
Obesity increased cancer risk by NKT cell depletion (PQ1)
$227,371Mark A Exley · Brigham And Women'S Hospital · R21 · FY2012 · CA
Identifying brain mediators distinguishing eustress and distress impact on cancer
$227,248Lei Cao · Ohio State University · R01 · FY2014 · CA